Armodafinil Market, Global Outlook and Forecast 2022-2028

March 2022 | 61 pages | ID: AB958EB965EEEN
Market Monitor Global

Abstracts

Armodafinil (trade name Nuvigil) is the enantiopure compound of the eugeroic modafinil (Provigil). It consists of only the (R)-(?)-enantiomer of the racemic modafinil.

This report contains market size and forecasts of Armodafinil in Global, including the following market information:

Global Armodafinil Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Armodafinil market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

50 mg Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Armodafinil include Teva, Mylan, Apotex, Lupin, Sandoz, Natco Pharma and Aurobindo, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Armodafinil companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Armodafinil Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Armodafinil Market Segment Percentages, by Type, 2021 (%)

• 50 mg Tablets
• 150 mg Tablets
• 200 mg Tablets
• 250 mg Tablets

Global Armodafinil Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Armodafinil Market Segment Percentages, by Application, 2021 (%)

• Obstructive Sleep Apnea (OSA) and Narcolepsy
• Shift Work Disorder (SWD)
• Patients with Severe Hepatic Impairment
• Geriatric Patients

Global Armodafinil Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Armodafinil Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Armodafinil revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Armodafinil revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Teva
• Mylan
• Apotex
• Lupin
• Sandoz
• Natco Pharma
• Aurobindo

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Armodafinil Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Armodafinil Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ARMODAFINIL OVERALL MARKET SIZE

2.1 Global Armodafinil Market Size: 2021 VS 2028
2.2 Global Armodafinil Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Armodafinil Players in Global Market
3.2 Top Global Armodafinil Companies Ranked by Revenue
3.3 Global Armodafinil Revenue by Companies
3.4 Top 3 and Top 5 Armodafinil Companies in Global Market, by Revenue in 2021
3.5 Global Companies Armodafinil Product Type
3.6 Tier 1, Tier 2 and Tier 3 Armodafinil Players in Global Market
  3.6.1 List of Global Tier 1 Armodafinil Companies
  3.6.2 List of Global Tier 2 and Tier 3 Armodafinil Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Armodafinil Market Size Markets, 2021 & 2028
  4.1.2 50 mg Tablets
  4.1.3 150 mg Tablets
  4.1.4 200 mg Tablets
  4.1.5 250 mg Tablets
4.2 By Type - Global Armodafinil Revenue & Forecasts
  4.2.1 By Type - Global Armodafinil Revenue, 2017-2022
  4.2.2 By Type - Global Armodafinil Revenue, 2023-2028
  4.2.3 By Type - Global Armodafinil Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Armodafinil Market Size, 2021 & 2028
  5.1.2 Obstructive Sleep Apnea (OSA) and Narcolepsy
  5.1.3 Shift Work Disorder (SWD)
  5.1.4 Patients with Severe Hepatic Impairment
  5.1.5 Geriatric Patients
5.2 By Application - Global Armodafinil Revenue & Forecasts
  5.2.1 By Application - Global Armodafinil Revenue, 2017-2022
  5.2.2 By Application - Global Armodafinil Revenue, 2023-2028
  5.2.3 By Application - Global Armodafinil Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Armodafinil Market Size, 2021 & 2028
6.2 By Region - Global Armodafinil Revenue & Forecasts
  6.2.1 By Region - Global Armodafinil Revenue, 2017-2022
  6.2.2 By Region - Global Armodafinil Revenue, 2023-2028
  6.2.3 By Region - Global Armodafinil Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Armodafinil Revenue, 2017-2028
  6.3.2 US Armodafinil Market Size, 2017-2028
  6.3.3 Canada Armodafinil Market Size, 2017-2028
  6.3.4 Mexico Armodafinil Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Armodafinil Revenue, 2017-2028
  6.4.2 Germany Armodafinil Market Size, 2017-2028
  6.4.3 France Armodafinil Market Size, 2017-2028
  6.4.4 U.K. Armodafinil Market Size, 2017-2028
  6.4.5 Italy Armodafinil Market Size, 2017-2028
  6.4.6 Russia Armodafinil Market Size, 2017-2028
  6.4.7 Nordic Countries Armodafinil Market Size, 2017-2028
  6.4.8 Benelux Armodafinil Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Armodafinil Revenue, 2017-2028
  6.5.2 China Armodafinil Market Size, 2017-2028
  6.5.3 Japan Armodafinil Market Size, 2017-2028
  6.5.4 South Korea Armodafinil Market Size, 2017-2028
  6.5.5 Southeast Asia Armodafinil Market Size, 2017-2028
  6.5.6 India Armodafinil Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Armodafinil Revenue, 2017-2028
  6.6.2 Brazil Armodafinil Market Size, 2017-2028
  6.6.3 Argentina Armodafinil Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Armodafinil Revenue, 2017-2028
  6.7.2 Turkey Armodafinil Market Size, 2017-2028
  6.7.3 Israel Armodafinil Market Size, 2017-2028
  6.7.4 Saudi Arabia Armodafinil Market Size, 2017-2028
  6.7.5 UAE Armodafinil Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Teva
  7.1.1 Teva Corporate Summary
  7.1.2 Teva Business Overview
  7.1.3 Teva Armodafinil Major Product Offerings
  7.1.4 Teva Armodafinil Revenue in Global Market (2017-2022)
  7.1.5 Teva Key News
7.2 Mylan
  7.2.1 Mylan Corporate Summary
  7.2.2 Mylan Business Overview
  7.2.3 Mylan Armodafinil Major Product Offerings
  7.2.4 Mylan Armodafinil Revenue in Global Market (2017-2022)
  7.2.5 Mylan Key News
7.3 Apotex
  7.3.1 Apotex Corporate Summary
  7.3.2 Apotex Business Overview
  7.3.3 Apotex Armodafinil Major Product Offerings
  7.3.4 Apotex Armodafinil Revenue in Global Market (2017-2022)
  7.3.5 Apotex Key News
7.4 Lupin
  7.4.1 Lupin Corporate Summary
  7.4.2 Lupin Business Overview
  7.4.3 Lupin Armodafinil Major Product Offerings
  7.4.4 Lupin Armodafinil Revenue in Global Market (2017-2022)
  7.4.5 Lupin Key News
7.5 Sandoz
  7.5.1 Sandoz Corporate Summary
  7.5.2 Sandoz Business Overview
  7.5.3 Sandoz Armodafinil Major Product Offerings
  7.5.4 Sandoz Armodafinil Revenue in Global Market (2017-2022)
  7.5.5 Sandoz Key News
7.6 Natco Pharma
  7.6.1 Natco Pharma Corporate Summary
  7.6.2 Natco Pharma Business Overview
  7.6.3 Natco Pharma Armodafinil Major Product Offerings
  7.6.4 Natco Pharma Armodafinil Revenue in Global Market (2017-2022)
  7.6.5 Natco Pharma Key News
7.7 Aurobindo
  7.7.1 Aurobindo Corporate Summary
  7.7.2 Aurobindo Business Overview
  7.7.3 Aurobindo Armodafinil Major Product Offerings
  7.7.4 Aurobindo Armodafinil Revenue in Global Market (2017-2022)
  7.7.5 Aurobindo Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Armodafinil Market Opportunities & Trends in Global Market
Table 2. Armodafinil Market Drivers in Global Market
Table 3. Armodafinil Market Restraints in Global Market
Table 4. Key Players of Armodafinil in Global Market
Table 5. Top Armodafinil Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Armodafinil Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Armodafinil Revenue Share by Companies, 2017-2022
Table 8. Global Companies Armodafinil Product Type
Table 9. List of Global Tier 1 Armodafinil Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Armodafinil Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Armodafinil Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Armodafinil Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Armodafinil Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Armodafinil Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Armodafinil Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Armodafinil Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Armodafinil Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Armodafinil Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Armodafinil Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Armodafinil Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Armodafinil Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Armodafinil Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Armodafinil Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Armodafinil Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Armodafinil Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Armodafinil Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Armodafinil Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Armodafinil Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Armodafinil Revenue, (US$, Mn), 2023-2028
Table 30. Teva Corporate Summary
Table 31. Teva Armodafinil Product Offerings
Table 32. Teva Armodafinil Revenue (US$, Mn), (2017-2022)
Table 33. Mylan Corporate Summary
Table 34. Mylan Armodafinil Product Offerings
Table 35. Mylan Armodafinil Revenue (US$, Mn), (2017-2022)
Table 36. Apotex Corporate Summary
Table 37. Apotex Armodafinil Product Offerings
Table 38. Apotex Armodafinil Revenue (US$, Mn), (2017-2022)
Table 39. Lupin Corporate Summary
Table 40. Lupin Armodafinil Product Offerings
Table 41. Lupin Armodafinil Revenue (US$, Mn), (2017-2022)
Table 42. Sandoz Corporate Summary
Table 43. Sandoz Armodafinil Product Offerings
Table 44. Sandoz Armodafinil Revenue (US$, Mn), (2017-2022)
Table 45. Natco Pharma Corporate Summary
Table 46. Natco Pharma Armodafinil Product Offerings
Table 47. Natco Pharma Armodafinil Revenue (US$, Mn), (2017-2022)
Table 48. Aurobindo Corporate Summary
Table 49. Aurobindo Armodafinil Product Offerings
Table 50. Aurobindo Armodafinil Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Armodafinil Segment by Type in 2021
Figure 2. Armodafinil Segment by Application in 2021
Figure 3. Global Armodafinil Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Armodafinil Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Armodafinil Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Armodafinil Revenue in 2021
Figure 8. By Type - Global Armodafinil Revenue Market Share, 2017-2028
Figure 9. By Application - Global Armodafinil Revenue Market Share, 2017-2028
Figure 10. By Region - Global Armodafinil Revenue Market Share, 2017-2028
Figure 11. By Country - North America Armodafinil Revenue Market Share, 2017-2028
Figure 12. US Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Armodafinil Revenue Market Share, 2017-2028
Figure 16. Germany Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 17. France Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Armodafinil Revenue Market Share, 2017-2028
Figure 24. China Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 28. India Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Armodafinil Revenue Market Share, 2017-2028
Figure 30. Brazil Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Armodafinil Revenue Market Share, 2017-2028
Figure 33. Turkey Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Armodafinil Revenue, (US$, Mn), 2017-2028
Figure 37. Teva Armodafinil Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Mylan Armodafinil Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Apotex Armodafinil Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Lupin Armodafinil Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sandoz Armodafinil Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Natco Pharma Armodafinil Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Aurobindo Armodafinil Revenue Year Over Year Growth (US$, Mn) & (2017-2022)